Investing Profile

George C. Petrocheilos

InvestorVCFounder
Co-Founder & Managing Partner at Catalio Capital Management
Photo of George C. Petrocheilos, Managing Partner at Catalio Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Catalio Capital Managing Partner
$100K - $5.0M
$1.5M
9
CompanyStageDateRound SizeTotal Raised
Clasp Therapeutics
Series AMar 2024$150M
$150M
Co-investors: R. Jacob Vogelstein (Catalio Capital), Andrea van Elsas (Third Rock Ventures), Jack Nielsen (Vivo Capital)
Haystack Oncology
Series ANov 2022$56M
$56M
Co-investors: R. Jacob Vogelstein (Catalio Capital)
Anagenex
Series AJun 2022$30M
$30M
Pheast Therapeutics
Series AApr 2022$76M
$76M
Co-investors: R. Jacob Vogelstein (Catalio Capital), Steven Gillis (ARCH Venture Partners)
Octant Bio
Series BApr 2022$80M
$190M
Co-investors: Stephen Hays (What If Ventures), Shawn Dimantha (Angel investor), Sujay Jaswa (WndrCo LLC)
DNA Script
Series CJan 2022$200M
Series COct 2021$170M
$470M
Co-investors: Nick Naclerio (Illumina Ventures), Joško Bobanović (Soffinova Partners), Philippe Peltier (Kurma Partners)
Sensei Biotherapeutics
Series BJan 2021$30M
$30M
Spiral Therapeutics
Series ADec 2018$6M
$6M
Co-investors: Sara Secall (Inveready Technology Investment Group)